🔗 Permalink

Inventor profile of:

Stephane Bancel

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Stephane Bancel

The entities that hold a legal rights for patent applications filed by inventor Bancel Stephane:

ModernaTX, Inc. 28 Cambridge, MA United States
MODERNA THERAPEUTICS, INC. 26 Cambridge, MA United States
modeRNA Therapeutics 1 Cambridge, MA United States

Recent patent applications by Bancel Stephane

Stephane Bancel from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250170228A1

Human necessities

TERMINALLY MODIFIED RNA

#2 | 2023-06-29

US20230203086A1

Chemistry; metallurgy

Ribonucleic acid purification

#3 | 2022-12-15

US20220395562A1

Human necessities

Terminally modified RNA

#4 | 2022-09-01

US20220273766A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

#5 | 2022-09-01

US20220273555A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS

#6 | 2021-09-30

US20210299278A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

#7 | 2021-07-29

US20210230578A1

Chemistry; metallurgy

REMOVAL OF DNA FRAGMENTS IN MRNA PRODUCTION PROCESS

#8 | 2021-04-22

US20210115101A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#9 | 2019-09-26

US20190290742A1

Human necessities

Terminally Modified RNA

#10 | 2019-08-08

US20190240351A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

#11 | 2019-04-04

US20190100748A1

Chemistry; metallurgy

Removal of DNA fragments in mRNA production process

#12 | 2019-03-21

US20190085368A1

Chemistry; metallurgy

MANUFACTURING METHODS FOR PRODUCTION OF RNA TRANSCRIPTS

#13 | 2019-01-31

US20190030129A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

#14 | 2018-12-20

US20180360995A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

#15 | 2018-11-08

US20180318446A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

#16 | 2018-11-01

US20180311381A1

Human necessities

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#17 | 2018-10-11

US20180291335A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR ALTERING CELL PHENOTYPE

#18 | 2018-09-27

US20180271938A1

Human necessities

Engineered nucleic acids and methods of use thereof

#19 | 2018-06-21

US20180170990A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

#20 | 2018-03-29

US20180086807A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#21 | 2018-01-04

US20180002393A1

Chemistry; metallurgy

Modified polynucleotides for the production of oncology-related proteins and peptides

#22 | 2018-01-04

US20180000910A1

Human necessities

Terminally modified RNA

#23 | 2017-12-28

US20170368200A1

Human necessities

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#24 | 2017-12-07

US20170348436A1

Human necessities

In vivo production of proteins

#25 | 2017-05-25

US20170143796A1

Human necessities

Engineered nucleic acids and methods of use thereof

#26 | 2017-03-09

US20170065675A1

Human necessities

Engineered nucleic acids and methods of use thereof

#27 | 2017-03-02

US20170056528A1

Human necessities

MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF

#28 | 2017-02-02

US20170028085A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

#29 | 2016-12-29

US20160375134A1

Human necessities

Modified polynucleotides for the production of secreted proteins

#30 | 2016-10-06

US20160289674A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS

#31 | 2016-09-22

US20160271272A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

#32 | 2016-09-08

US20160256573A1

Human necessities

MODIFIED NUCLEIC ACIDS, AND ACUTE CARE USES THEREOF

#33 | 2016-09-08

US20160256572A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF FOR NON-HUMAN VERTEBRATES

#34 | 2016-07-21

US20160205924A1

Human necessities

METHODS OF INCREASING THE VIABILITY OR LONGEVITY OF AN ORGAN OR ORGAN EXPLANT

#35 | 2016-07-14

US20160199513A1

Human necessities

Modified polynucleotides for the production of proteins associated with human disease

#36 | 2016-06-09

US20160158385A1

Human necessities

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#37 | 2016-06-02

US20160152678A1

Chemistry; metallurgy

Modified polynucleotides for the production of oncology-related proteins and peptides

#38 | 2016-06-02

US20160151516A1

Human necessities

Modified polynucleotides for the production of proteins

#39 | 2016-04-28

US20160114011A1

Human necessities

Modified polynucleotides for the production of nuclear proteins

#40 | 2016-03-17

US20160075733A1

Chemistry; metallurgy

Modified polynucleotides for the production of biologics and proteins associated with human disease

#41 | 2016-01-28

US20160024547A1

Chemistry; metallurgy

Manufacturing methods for production of RNA transcripts

#42 | 2016-01-28

US20160024492A1

Chemistry; metallurgy

Removal of DNA fragments in mRNA production process

#43 | 2016-01-28

US20160024171A1

Chemistry; metallurgy

Engineered nucleic acids and methods of use thereof

#44 | 2016-01-28

US20160024140A1

Chemistry; metallurgy

Ribonucleic acid purification

#45 | 2016-01-28

US20160022774A1

Human necessities

DIAGNOSIS AND TREATMENT OF FIBROSIS

#46 | 2015-12-31

US20150376648A1

Chemistry; metallurgy

In vivo production of proteins

#47 | 2015-12-24

US20150368665A1

Chemistry; metallurgy

Modified polynucleotides for the production of secreted proteins

#48 | 2015-11-05

US20150315541A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR ALTERING CELL PHENOTYPE

#49 | 2015-09-03

US20150246139A1

Human necessities

Modified polynucleotides for the production of nuclear proteins

#50 | 2015-06-18

US20150166616A1

Chemistry; metallurgy

Modified polynucleotides for the production of cosmetic proteins and peptides

#51 | 2015-05-21

US20150141499A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

#52 | 2015-04-23

US20150111248A1

Chemistry; metallurgy

In vivo production of proteins

#53 | 2015-03-26

US20150086614A1

Chemistry; metallurgy

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#54 | 2015-03-05

US20150064236A1

Human necessities

Modified polynucleotides for the production of proteins

#55 | 2015-03-05

US20150064235A1

Chemistry; metallurgy

Modified polynucleotides

#56 | 2015-02-26

US20150056253A1

Chemistry; metallurgy

Engineered nucleic acids and methods of use thereof

#57 | 2015-02-19

US20150051268A1

Human necessities

METHODS OF INCREASING THE VIABILITY OR LONGEVITY OF AN ORGAN OR ORGAN EXPLANT

#58 | 2015-02-12

US20150044277A1

Human necessities

MODIFIED POLYNUCLEOTIDES ENCODING CASPASE 3

#59 | 2015-01-29

US20150030576A1

Human necessities

METHODS AND COMPOSITIONS FOR TARGETING AGENTS INTO AND ACROSS THE BLOOD-BRAIN BARRIER

#60 | 2014-12-25

US20140378538A1

Human necessities

METHODS OF RESPONDING TO A BIOTHREAT

#61 | 2014-11-20

US20140343129A1

Chemistry; metallurgy

MODIFIED NUCLEIC ACIDS, AND ACUTE CARE USES THEREOF

#62 | 2014-09-18

US20140275229A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES ENCODING UDP GLUCURONOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1

#63 | 2014-09-11

US20140255468A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES ENCODING PROGRAMMED CELL DEATH 1

#64 | 2014-09-11

US20140255467A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES ENCODING CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4

#65 | 2014-09-04

US20140249208A1

Chemistry; metallurgy

Modified polynucleotides for treating protein deficiency

#66 | 2014-08-28

US20140243399A1

Chemistry; metallurgy

Engineered nucleic acids and methods of use thereof

#67 | 2014-07-24

US20140206755A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR TREATING ARYLSULFATASE A PROTEIN DEFICIENCY

#68 | 2014-07-17

US20140200264A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR TREATING CARBOXYPEPTIDASE N, POLYPEPTIDE 1 PROTEIN DEFICIENCY

#69 | 2014-07-17

US20140200263A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR TREATING GALACTOSIDASE, ALPHA PROTEIN DEFICIENCY

#70 | 2014-07-17

US20140199371A1

Chemistry; metallurgy

Modified polynucleotides encoding basic helix-loop-helix family member E41

#71 | 2014-07-10

US20140194494A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR TREATING PROTEIN DEFICIENCY

#72 | 2014-07-10

US20140193482A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES ENCODING V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG

#73 | 2014-07-03

US20140186432A1

Human necessities

Modified polynucleotides encoding citeD4

#74 | 2014-06-19

US20140171485A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES ENCODING CD28 MOLECULE

#75 | 2014-05-29

US20140147454A1

Human necessities

Terminally modified RNA

#76 | 2014-04-17

US20140105966A1

Chemistry; metallurgy

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

#77 | 2013-10-03

US20130259924A1

Chemistry; metallurgy

Modified polynucleotides for the production of biologics and proteins associated with human disease

#78 | 2012-03-15

US20120065252A1

Human necessities

Engineered nucleic acids and methods of use thereof

InventorID:

806923 ⎘